Cookies on this site

Our group uses synthetic chemistry and biochemistry to develop small-molecule therapeutics and generate new insights into fundamental biology. We are interested in using tool molecules and interdisciplinary methodology to identify and validate new drug targets and mechanisms of action.

Docking pose of 'RUSKI-201' small-molecule inhibitor

MEDICINAL CHEMISTRY

As part of the Medicinal Chemistry Group in the Department of Pharmacology, our research involves the synthesis and development of biologically active small molecules. This includes identification of new inhibitors by screening approaches, design of improved molecules using rational and computational guidance, and testing of molecules in biochemical, cellular and in vivo settings. Current Medicinal Chemistry projects include: development of new approaches to slow or reverse antibiotic resistance; non-natural modulation of protease activity; light-activated therapies for treatment of cancer.

CHEMICAL BIOLOGY

Our research in Chemical Biology involves the use of chemical methodology and tool molecules to probe biological questions. This encompasses a range of techniques including organic synthesis, bioorthogonal 'click' chemistry, and biochemical or mass spectrometry-based proteomic analyses. Current areas of interest include: profiling of small-molecule targets in live cells using chemoproteomics; synthetic functionalisation of proteins; use of machine-learning for analysis and optimisation of biochemical processes. 

JOINING THE LAB

We are always on the lookout for motivated people to join our group. If interested, please make contact to discuss further (thomas.lanyon-hogg@pharm.ox.ac.uk). At the postdoctoral level, we are willing to support applications to fellowship programmes. At the PhD student level, recruitment is conducted via one of the Oxford University doctoral training programmes; please note that these programmes normally close in January each year. We particularly welcome interest from groups that are under-represented in scientific research.  

Our team

Recent publications

Molecular Glue Degraders of TEM β-Lactamases by Periplasmic Protease DegP.

Journal article

Taylor EK. et al, (2026), Angew Chem Int Ed Engl

Molecular Glue Degraders of TEM β‐Lactamases by Periplasmic Protease DegP

Journal article

Taylor EK. et al, (2026), Angewandte Chemie

Discovery of Stereoselective Targeted Covalent Inhibitors of the RAB27-Effector Protein-Protein Interaction.

Journal article

De Vita E. et al, (2026), J Am Chem Soc, 148, 40880 - 40888

Small-molecule inhibitors block NorA efflux by conformational trapping.

Journal article

Gray JL. et al, (2026), Nat Chem Biol

Alumni

Postdoctoral researchers: 2023: Adam Thomas; 2022: Om Tanwar.

PhD/DPhil: 2026: Jacob Bradbury, Nadira Rakhi. 

MSc/Part II: 2026: Elizabeth Hardy, Tarini Kadambi, Rhonda Tse, Summer Xia; 2025: Madia Harvey, Hildur Hreidarsdottir, James Simons, Yiqiao Wang, Tanya Watson; 2024: Amelia Abbott, Lauren Kim, Luke MacKay, Kayla Rowden, Soraya Saghbini, Tricia Seow; 2023: Arina Belov, Isla Sandeman, Amy Stonehouse, Adam Winnifrith; 2022: Kiera Gilbert, Thomas Hodgkinson, Anna McDonald, Vasiliki Mina; 2021: Jemima Brimacombe, Nicholas Etherington.

BSc: 2021: Jasmine Harris, Tara Shutes.

Visiting researchers: 2025: Jovana Stijepic (TU Munich); 2024: Cherry Marsh (Oxford); 2023: Why Wong (Cambridge); 2022: Gabriele La Monica (Palermo), Vanessa Rogga (Zagreb); 2021: Marine Guingand (Paris), Sarah Kapllani Mucaj (Cambridge).

Collaborating labs

Dr Kerstin Timm (Pharmacology)

Prof. Timothy Walsh (Zoology)

Dr Georgia Isom (Pathology)

Prof. Ben Davis (Pharmacology & Rosalind Franklin Institute)

Prof. Angela Russell (Pharmacology & Chemistry)

Prof. Ming Lei (Pharmacology)

Related research themes